Pharmacists in Wilmington, MA Accepting Medicare

12 Pharmacists found. Showing 1 - 12

Monica Beatriz Leonard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 277 Main St, Wilmington, MA 01887 Phone: 978-657-9401

Ms. Gelisha M. Zegri, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 Pouliot Pl, Wilmington, MA 01887 Phone: 978-988-7824

Rachel Bell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 Main St, Wilmington, MA 01887 Phone: 978-988-0232

Dr. Janet Mbugua, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 222 Main St, Wilmington, MA 01887 Phone: 978-658-3377    Fax: 978-988-7969

David Wojtczak, R.P.H. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 Main Street, Wilmington, MA 01887 Phone: 978-988-0232    Fax: 978-988-1958

James Michael Rice Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 260d Fordham Rd, Wilmington, MA 01887 Phone: 978-657-8200    Fax: 978-657-8220

Mr. John Francis Balliro Sr., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 260d Fordham Rd, Wilmington, MA 01887 Phone: 978-657-8200

Haydeh Panahi Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 222 Main St, Wilmington, MA 01887 Phone: 978-658-3377

Laurie Jean Dowling, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 277 Main St, Wilmington, MA 01887 Phone: 978-657-9401    Fax: 978-657-9407

Yogina P Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 277 Main St, Wilmington, MA 01887 Phone: 978-657-9401

Abigail Kaplan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 222 Main St, Wilmington, MA 01887 Phone: 978-658-3377

Mrs. Patricia Marie Magee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Mill Rd, Wilmington, MA 01887 Phone: 978-658-5442

News Archive

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.

New research unit at JGU examines extreme experiences in human life using biomedical explanations

The German Research Foundation (DFG) is establishing a new research unit at Johannes Gutenberg University Mainz (JGU). The interdisciplinary group will examine how new biomedical capabilities can lead to extreme experiences in human life.

Data from past epidemic could help improve response to future Ebola outbreaks

Data from the 2014 Ebola virus outbreak at two Sierra Leone facilities reveal daily usage rates for disinfectant and personal protective equipment, informing future outbreaks, according to a study published May 24, 2018 in the open-access journal PLOS ONE by Michaela Mallow of International Medical Corps in Los Angeles, CA, and colleagues.

Watson's ANDA for Fentanyl Citrate Buccal tablets receives tentative FDA approval

Watson Pharmaceuticals, Inc. announced that its subsidiary, Watson Laboratories, Inc. has received tentative approval today from the United States (U.S.) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Fentanyl Citrate Buccal tablets, 100 mcg, 200 mcg, 300 mcg, 400 mcg, 600 mcg and 800 mcg.

Read more Medical News

› Verified 4 days ago